Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Jul 2013 12:02

RNS Number : 2771I
Amphion Innovations PLC
01 July 2013
 



 

Amphion Innovations plc

Directors Shareholding

 

London and New York, 01 July 2013 - Amphion Innovations plc (LSE: AMP) (the "Company" or "Amphion") was today advised, that Richard Morgan, CEO of Amphion, purchased 200,000 ordinary shares at 1.75 pence per ordinary shares on 28 June 2013 in the Company. Accordingly, Richard Morgan is now beneficially interested in 25,642,499 ordinary shares, representing 17.54 per cent of its issued ordinary share capital.

 

 

For further information please contact

Amphion InnovationsCharlie Morgan+1 212 210 6224

Novella CommunicationsTim Robertson+44 (0)7900 927 650

Panmure Gordon LimitedFreddy Crossley/ Fred Walsh/ Grishma Patel (Corporate Finance)

Adam Pollock/ Victoria Boxall (Corporate Broking)+44 (0)20 7866 2500

 

About Amphion Innovations plc

 Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: www.amphionplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFLFBXDFBBBL
Date   Source Headline
8th Jun 20067:01 amRNSAppointment
6th Jun 20067:01 amRNSRe Agreement
5th Jun 20063:16 pmRNSThe Shafallah Center
2nd Jun 20065:01 pmRNSDr David Evans
1st Jun 20067:00 amRNSAnnual Report and Accounts
23rd May 20067:00 amRNSDirector/PDMR Shareholding
22nd May 20061:41 pmRNSDirector/PDMR Shareholding
19th May 20065:12 pmRNSDirector Share Transaction
15th Mar 20069:25 amRNSCompletion of a Financing
8th Mar 20067:04 amRNSFinal Results
2nd Mar 20069:12 amRNSMotif BioSciences
27th Feb 20064:56 pmRNSNotice of Results
23rd Feb 20067:02 amRNSRe: WellGen Financing
3rd Jan 20067:01 amRNSAdditional Investments
5th Dec 200512:48 pmRNSDirector Shareholding
10th Oct 20057:00 amRNSAcquires a stake
21st Sep 20057:00 amRNSStake in Spin-Out Company
30th Aug 20057:00 amRNSAmphion Invests in WellGen
25th Aug 20054:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.